Receptors for Purines and Pyrimidines
Authors:
- Vera RalevicVRVera Ralevic
- Geoffrey BurnstockGBGeoffrey Burnstock
- 1 September 1998
- journal article
- review article
- Published by Elsevier in Pharmacological Reviews
- Vol. 50 (3) , 413-492
Abstract
No abstract availableThis publication has 930 references indexed in Scilit:
- Pharmacology of 2-cyclohexylmethylidenehydrazinoadenosine (WRC-0470), a novel, short-acting adenosine A2A receptor agonist that produces selective coronary vasodilationDrug Development Research, 1997
- Receptor nomenclatureDrug Development Research, 1996
- Role of adenosine in asthmaDrug Development Research, 1996
- Expression of multiple ATP receptor subtypes during the differentiation and inflammatory activation of myeloid leukocytesDrug Development Research, 1996
- ATP-evoked inositol phosphates formation through activation of P2U purinergic receptors in cultured astrocytes: Regulation by PKC subtypes α, δ, and θGlia, 1996
- Numbering of cloned P2 purinoceptorsDrug Development Research, 1996
- Extracellular ATP causes loss of L-selectin from human lymphocytes via occupancy of P2Z purinoceptorsJournal of Cellular Physiology, 1996
- Nucleotide receptor P2u partially mediates ATP-induced cell cycle progression of aortic smooth muscle cellsJournal of Cellular Physiology, 1996
- Molecular characterization of A1 and A2a adenosine receptorsDrug Development Research, 1993
- Inotropic actions of adenosine derivatives in the mammalian heartDrug Development Research, 1993